John V. Oyler
From Wikipedia, the free encyclopedia
John V. Oyler | |
|---|---|
| Born | 1968 (age 57–58) Pittsburgh, Pennsylvania |
| Alma mater | Massachusetts Institute of Technology |
| Occupation | Entrepreneur |
| Known for | BeOne |
John V. Oyler (born 1968) is an American executive.[1] He is known for co-founding BeOne, a biotechnology company, with biochemist Xiaodong Wang.[2]
Oyler grew up in Pittsburgh, Pennsylvania. He attended the Massachusetts Institute of Technology.[3] He graduated with a degree in mechanical engineering in 1990.[2][4]
Career
Oyler began his career as a consultant at McKinsey & Company, which often involved travel to China.[5] During his time at McKinsey, he earned an MBA degree from Stanford University and continued to work there after graduate school.[2]
Oyler joined Genta, a biotechnology company focused on cancer drugs, in 1997. At Genta, Oyler hired new management and grew the company's valuation from a few million dollars to $1.7 billion.
In 1998, Oyler was a founder of Telephia, a telecom research company where he served as president.[6][5][7] Nielsen Holdings acquired Telephia in 2007.[8] Oyler was also headed Galenea, a company focused on treatments for psychiatric diseases,[9] from 2002 to 2004.[10]
In 2005, Oyler returned to China[5] and co-founded BioDuro, a contract research organization.[9] PPD acquired BioDuro in 2009.[11]
BeOne
Oyler co-founded the company in 2010 with Chinese biochemist Xiaodong Wang, whom Oyler met while working at BioDuro.[2]
The company has developed two cancer medicines, namely Tevimbra, a checkpoint inhibitor, and Brukinsa, a Bruton's tyrosine kinase inhibitor.[3] As of 2025, BeOne has 11,000 employees.[12]
Personal life
Oyler is married and has one daughter.